Cite Filings / EMMA / 0001140361-21-034358

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Emmaus Life Sciences, Inc. Filed 2021-10-12 Acc 0001140361-21-034358

Documents 1

DEF 14A Proxy Statement , ny20000854x2_def14a.htm

Around this filing

2022-10-31 DEF 14A Proxy Statement
2021-10-12 8-K Material agreement
2021-10-12 DEF 14A Proxy Statement
2021-10-07 4 Chairman and CEO bought 3,000 shares at an average $1.61 ($4,840)
2018-11-02 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading ny20000854x2_def14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…